Molecular mechanisms underlying HLA-DR-associated susceptibility to autoimmunity

International Journal of Cardiology

Volumn 54, Issue SUPPL., 1996, Pages

  Matsushita, Sho ^a   Fujisao, Shoji ^a   Nishimura, Yasuharu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Autoimmunity; HLA DR; Molecular mechanisms; Takayasu arteritis

Indexed keywords

HLA DR ANTIGEN; HLA DR4 ANTIGEN;

AORTA ARCH SYNDROME; AUTOIMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; ETIOLOGY; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; PRIORITY JOURNAL;

EID: 0029790902     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-5273(96)02637-X     Document Type: Conference Paper

References (16)

1. Dong R-P, Kimura A, Numano F, Yajima M, Hashimoto Y, Kishi Y, Nishimura Y, Sasazuki T. HLA-DP antigen and Takayasu arteritis. Tissue Antigens 1992;39:106.
2. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993;364:33.
3. Rudensky AY, Preston-Hurlburt P, Hong S-C, Barlow A, Janeway Jr, CA. Sequence analysis of peptides bound to MHC class II molecules. Nature 1991;353:622.
4. Uchigata Y, Omori Y, Nieda M, Kuwata S, Tokunaga K, Juji T. HLA-DR4 genotype and insulin-processing in insulin autoimmune syndrome. Lancet 1992;340:1467.
5. Matsuki K, Juji T, Tokunaga K, Takamizawa M, Maeda H, Soda M, Nomura Y, Segawa M. HLA antigens in Japanese patients with myasthenia gravis. J Clin Invest 1990;86:392.
6. Panina-Bordignon P, Tan A, Termijtelen A, Demotz S, Corradin G, Lanzavecchia A. Universally immunogenic T cell epitopes: promiscuous recognition by T cells. Eur J Immunol 1989;19:2237.
7. Hirayama K, Nishimura Y, Tsukamoto K, Sasazuki T. Functional and molecular analysis of three distinct HLA-DR4 β-chains responsible for the MLR between HLA-Dw4, Dw15, and DKT2. J Immunol 1986;137:924.
8. Matsushita S, Takahashi K, Motoki M, Komoriya K, Ikagawa S, Nishimura Y. Allele specificity of structural requirement for peptides bound to HLA-DRBI*0405 and -DRBI*0406 complexes: Implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J Exp Med 1994;180:873.
9. Koide Y, Awashima F, Yoshida TO, Takenouchi T, Wakisaka A, Moriuchi J, Aizawa M. The role of three distinct Ia-like antigen molecules in human T cell proliferative responses: Effect of monoclonal anti-Ia-like antibodies. J Immunol 1982;129:1061.
10. Scott JK, Smith GP. Searching for peptide ligands with an epitope library. Science 1990;249:386.
11. Demotz S, Barbey C, Corradin G, Amoroso A, Lanzavecchia A. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. Eur J Immunol 1993;23:425.
12. Krieger JI, Karr RW, Grey HM, Yu W-Y, O'Sullivan D, Batovsky L, Zheng Z-L, Col-n SM, Gaeta FCA, Sidney J, Albertson M, del Guercio M-F, Chesnut RW, Sette, A. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition. J Immunol 1991;146:2331.
13. Hammer J, Bono E, Gallazzi F, Belunis C, Nagy Z, Sinigaglia F. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J Exp Med 1994;180:2353.
14. Boehncke W-H, Takeshita T, Pendleton CD, Houghten RA, Sadegh-Nasseri S, Racioppi L, Berzofsky JA, Germain RN. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. J Immunol 1993;150:331.
15. Moiola L, Protti MP, Manfredi AA, Yuen M-H, Howard Jr. JF, Coti-Tronconi BM, T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis. Ann NY Acad Sci 1993;681:198.
16. 2-glycoprotein I (apolipoprotain H). Proc Natl Acad Sci USA 1990;87:4120.